The United Network for Organ Sharing (UNOS) earlier this month celebrated its millionth organ transplant, in today's bite-sized hospital and health industry news from California, Illinois, and Virginia.

• California: Gilead Sciences earlier this month settled patent disputes with generic drugmakers Apotex Inc, Lupin Ltd, Cipla Ltd, Macleods Pharmaceuticals Ltd, and Hetero Labs Ltd over proposed generic versions of HIV and hepatitis B drugs. According to a filing with the Securities and Exchange Commission (SEC), the generic drugmakers will receive non-exclusive licenses to Gilead's patents, which will allow them to sell generic versions of HIV drugs Descovy and Odefsey as early as October 2031 and hepatitis B drug Vemlidy in January 2032. While the SEC filing did not provide additional details on the settlement, it noted that the licenses could be obtained earlier "in certain circumstances." (Brittain, Reuters, 9/12)

• Illinois: Providers who received Provider Relief Fund (PRF) payments totaling more than $10,000 between Jan. 1 and June 30, 2021, are required to report how they used their funds to the Health Resources and Services Administration no later than Sept. 30. Providers who fail to do so will face enforcement actions, including repayment or being excluded from receiving or retaining future PRF payments. (AHA News, 9/12)

• Virginia: UNOS—the United States' organ transplant system—earlier this month reported its millionth organ transplant. UNOS and the Organ Donation and Transplantation Alliance attributed the historic accomplishment to the organ donation and transplantation community. The organizations urged members of the transplant community to join Living It Forward—a national program designed to celebrate the milestone and accelerate the path to the next million transplants. In addition, they encouraged members of the public to register as organ donors, adding that a single donor can save up to eight lives and provide tissue donations to up to 75 people. Currently, more than 100,000 people are on the transplant waitlist. (AHA News, 9/12)